Radiotherapy can play its immune-stimulating role and enhance the killing effects of the immune system on GBM cells by reducing the aggregation of infiltrating regulatory T cells (Treg) lymphocytes in tissues and inhibiting the PD-1/PDL-1 pathway (Portella and Scala, 2019). The gene discussed is CD274; the disease is glioblastoma.